SOX9 and non-small cell lung carcinoma: Pemetrexed-induced simultaneous SLUG and Sox9 overexpression in NSCLC cells are correlated with increased EMT and an enhanced propensity for metastasis [34], as reflected in our invasion assay data (Figure 2 and Figure 6).